COMMUNIQUÉS West-GlobeNewswire

Aeglea BioTherapeutics Announces Pricing of $60.0 Million Public Offering
06/02/2019
AUSTIN, Texas, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (Nasdaq:AGLE) a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare [...]
Trevena to Present at the 21st Annual BIO CEO & Investor Conference
06/02/2019
CHESTERBROOK, Pa., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of new and innovative treatment options for patients in pain [...]
Terranueva Grants Options
06/02/2019
MONTRÉAL, Feb. 05, 2019 (GLOBE NEWSWIRE) -- TERRANUEVA CORPORATION (“Terranueva” or the “Company”) announces the grant to its directors, officers, employees and consultants of an aggregate of 2,225,000 stock options to [...]
Terranueva attribue des options
06/02/2019
MONTRÉAL, 05 févr. 2019 (GLOBE NEWSWIRE) -- CORPORATION TERRANUEVA (la « Société » ou « Terranueva ») annonce l’attribution à ses administrateurs, dirigeants, employés et consultants d´un total de 2 225 000 d'options d' [...]
Management Cease Trade Order Update
06/02/2019
HALIFAX, Nova Scotia, Feb. 05, 2019 (GLOBE NEWSWIRE) -- MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued [...]
CDN MSolar and Blueberries Cannabis Complete Business Combination to Form Blueberries Medical Corp; Shares to Commence Trading February 6, 2019 Under the Symbol “BBM”
05/02/2019
TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (the “ Company ” or " Blueberries ") is pleased to announce the completion of its business combination with Blueberries Cannabis Corp. (the [...]
Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock
05/02/2019
AUSTIN, Texas, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (Nasdaq:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare [...]
Rockwell Medical, Inc. to Present at 2019 BIO CEO & Investor Conference
05/02/2019
WIXOM, Mich., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at the 2019 BIO CEO [...]
Sientra Announces miraDry Leadership Transition
05/02/2019
SANTA BARBARA, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that it has appointed Kirk Gunhus to the position of General Manager of miraDry, [...]
ReWalk Robotics to Report Fourth Quarter and Year-End 2018 Financial Results on February 8, 2019
05/02/2019
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Feb. 05, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter and year- [...]
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2018 Financial Results on February 26
05/02/2019
MINNEAPOLIS, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Globus Medical Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call
05/02/2019
AUDUBON, Pa., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31 [...]
AIT Therapeutics Schedules Fiscal Third Quarter 2019 Financial Results Conference Call and Webcast
05/02/2019
Call scheduled for Wednesday, February 13th at 4:30pm Eastern Time. NEW YORK, Feb. 05, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused [...]
aTyr Pharma to Present at the BIO CEO & Investor Conference
05/02/2019
SAN DIEGO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]
Paratek Pharmaceuticals Launches NUZYRA™ (Omadacycline) in the United States
05/02/2019
-- Three Antimicrobial Susceptibility Tests Cleared by FDA for Use with NUZYRA -- -- Launches KEYSTONE TM Surveillance Program to Monitor Omadacycline Susceptibility -- BOSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Paratek [...]
Myriad Genetics Reports Fiscal Second-Quarter 2019 Financial Results
05/02/2019
Total Second-Quarter Revenues of $216.8 Million, Up 15 Percent Second-Quarter Diluted EPS of $0.03 and Adjusted EPS of $0.38, Up 6 Percent SALT LAKE CITY, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ [...]
Emblem Corp. Announces Receipt of Interim Court Order and Mailing of Meeting Materials Related to its Special Meeting of Shareholders and Proposed Arrangement with Aleafia Health Inc.
05/02/2019
TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“ Emblem ” or the “ Company ”) announces that the Ontario Superior Court of Justice (Commercial List) granted the Company’s motion for [...]
Cerner Reports Fourth Quarter and Full Year 2018 Results and Announces Plan to Initiate Quarterly Cash Dividend
05/02/2019
Fourth Quarter Bookings 2nd Highest in Cerner History KANSAS CITY, Mo., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced results for the 2018 fourth quarter and full year that ended [...]
Amicus Therapeutics Announces Positive data in Pompe Disease Phase 1/2 Study for Up to 24 Months at 15th Annual WORLDSymposium™
05/02/2019
Consistent and Durable Responses Across Key Measures of Safety, Functional Outcomes and Biomarkers Continue for both ERT-Naïve and ERT-Switch Patients Patient Reported Outcomes Data Demonstrate Benefits in Activities of [...]

Pages